Results 171 to 180 of about 11,986 (188)

Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives

Current Pharmaceutical Design, 2022
John Rendu, Isabelle Marty
exaly  

Intracellular calcium leak as a therapeutic target for RYR1-related myopathies

Acta Neuropathologica, 2020
Katherine G Meilleur, Zephan Melville
exaly  

RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction

Current Pharmaceutical Design, 2022
Nick Kruijt, Susan Treves
exaly  

RYR1 genotype of the Chinese neijiang pig

Transplantation Proceedings, 2000
H, Bu, Y, Chen, J, Liu, S, Li, J, Cheng, Y, Li   +5 more
openaire   +2 more sources

RYR1 Modulation by Calmodulin

2005
Paula Aracena, Cecilia Hidalgo, Susan L. Hamilton   +2 more
openaire   +1 more source

Neuromuscular symptoms in patients with RYR1-related malignant hyperthermia and rhabdomyolysis.

Brain Communications, 2022
Susan Treves, Miguel A Fernandez-Garcia
exaly  

RYR1-related myopathies: a wide spectrum of phenotypes throughout life

European Journal of Neurology, 2015
Hans Scheffer, Joost Raaphorst, Martin Lammens   +2 more
exaly  

Ryanodine receptor type-1 (RyR1) expression and protein S-nitrosylation pattern in human soleus myofibres following bed rest and exercise countermeasure

Histochemistry and Cell Biology, 2008
Joern Rittweger, Michele Salanova, Dieter Blottner   +2 more
exaly  

Top bar navigation

Frontiers in Physiology, 2016
Richard M Lovering, Erick O Hernández-Ochoa, Martin F Schneider   +2 more
exaly  

Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis

Neuromuscular Disorders, 2013
Baziel van Engelen, Martin Lammens, Nicol Voermans   +2 more
exaly